Thermo Fisher Scientific (TMO) Inventory (2009 - 2026)

Thermo Fisher Scientific has disclosed Inventory across 18 years of filings, most recently posting $5.5 billion for Q1 2026.

• Quarterly Inventory rose 5.21% year-over-year to $5.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 billion (up 5.21% YoY) and the FY2025 annual result came in at $5.4 billion, up 8.98% from the prior year.
• Inventory improved to $5.5 billion in Q1 2026, from $5.4 billion in the prior quarter.
• Over five years, Inventory peaked at $5.7 billion in Q3 2025 and troughed at $5.0 billion in Q4 2024.
• A 5-year average of $5.4 billion and a median of $5.5 billion in 2022 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory surged 28510.0% — and 2023, when it slipped 9.69%.
• Tracing TMO's Inventory over 5 years: stood at $5.6 billion in 2022, then fell by 9.69% to $5.1 billion in 2023, then slipped by 2.16% to $5.0 billion in 2024, then climbed by 8.98% to $5.4 billion in 2025, then grew by 1.31% to $5.5 billion in 2026.
• Business Quant data shows TMO's Inventory at $5.5 billion in Q1 2026, $5.4 billion in Q4 2025, and $5.7 billion in Q3 2025.